Last reviewed · How we verify

NCT06963671

Blood Flow Restriction for Ulnar Sided Wrist Pain

ENROLLING BY INVITATION NA Last updated 3 October 2025
What this trial tests

NA trial testing Blood Flow Restriction in Ulnar Wrist Pain in 90 participants. Enrolling by invitation.

Timeline
11 August 2025
Primary endpoint
31 December 2028
31 December 2028

Quick facts

Lead sponsorStanford University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingnone
Primary purposetreatment
Enrollment90
Start date11 August 2025
Primary completion31 December 2028
Estimated completion31 December 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Ulnar Wrist Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the strength, pain and functional benefits of early, low-load resistance training with blood flow restriction (BFR) in ulnar-sided wrist pain treated nonoperatively with immobilization for 4-6 weeks. Hypothesis: patients in the BFR group with have improved grip strength and patient reported outcome measure scores compared to the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood Flow Restriction

Trials testing the same drug.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06963671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing